Status:
COMPLETED
A Study to Test the Effect of MK0217A on Vitamin D Inadequacy in Postmenopausal Women With Osteoporosis (0217A-262)
Lead Sponsor:
Organon and Co
Conditions:
Osteoporosis
Eligibility:
FEMALE
65+ years
Phase:
PHASE3
Brief Summary
A study designed to see if the study drug will increase blood levels of vitamin D, bone mineral density (BMD), improve biochemical markers of bone turnover, and reduce the number of falls as compared ...
Eligibility Criteria
Inclusion
- Female
- 65 years or older
- Diagnosed with osteoporosis (Bone Mineral Density (BMD) T-score \<= -2.5 at spine or hip) or prior fragility fracture BMD T-score \<=-1.5 in at least one of the anatomic sites including lumbar spine, total hip, and femoral neck sites
- Postmenopausal
- Low levels of vitamin D as measured 25-hydroxyvitamin D
- Has fallen at least once within the past 12 months
Exclusion
- Unable to stand or sit upright for at least 30 minutes
- Has a bone disorder other than osteoporosis
- Contraindication to the use of FOSAVANCE
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
515 Patients enrolled
Trial Details
Trial ID
NCT00692913
Start Date
June 1 2008
End Date
July 1 2010
Last Update
May 9 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.